نتائج البحث - "Blommestein, H.M."

1

دورية أكاديمية

Changes in survival in de novo metastatic cancer in an era of new medicines

المؤلفون: Luyendijk, M., Visser, O., Blommestein, H.M., de Hingh, I.H.J.T., Hoebers, F.J.P., Jager, A., Sonke, G.S., de Vries, E.G.E., Groot, C.A.U.D., Siesling, S.

المصدر: Luyendijk , M , Visser , O , Blommestein , H M , de Hingh , I H J T , Hoebers , F J P , Jager , A , Sonke , G S , de Vries , E G E , Groot , C A U D & Siesling , S 2023 , ' Changes in survival in de novo metastatic cancer in an era of new medicines ' , Journal of the National Cancer Institute , vol. 115 , no. 6 , pp. 628-635 . https://doi.org/10.1093/jnci/djad020Test

مصطلحات موضوعية: TRENDS, EPIDEMIOLOGY, IMATINIB, EUROPE, TUMORS, DRUGS, STAGE, UK

العلاقة: https://cris.maastrichtuniversity.nl/en/publications/7d446e28-34dd-4d40-aa5f-3fb9eb672131Test

الإتاحة: https://doi.org/10.1093/jnci/djad020Test
https://cris.maastrichtuniversity.nl/en/publications/7d446e28-34dd-4d40-aa5f-3fb9eb672131Test

View record in BASE

2

دورية أكاديمية

P53 REAL-WORLD TREATMENT SEQUENCES AND COSTS OF 96 PATIENTS WITH MULTIPLE MYELOMA FROM DIAGNOSIS TO DEATH

المؤلفون: Seefat, M.R., Cucchi, D.G.J., Groen, K., Donker, M.L., van der Hem, K.G., Westerman, M., Gerrits, A.M., Beeker, A., van de Donk, N., Blommestein, H.M., Zweegman, S.

المصدر: HemaSphere ; volume 7, issue S2, page 39-40 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000936340.30450.37Test

View record in BASE

3

دورية أكاديمية

RW3 The Use of Real-World Evidence in HTA of CLASS III Medical Devices in Europe

المؤلفون: Klein, P., de Groot, S., Blommestein, H.M., Pongiglione, B., Torbica, A., Al, M.J.

المصدر: Value in Health ; volume 23, page S758 ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2020.08.2083Test
https://api.elsevier.com/content/article/PII:S1098301520343394?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301520343394?httpAccept=text/plainTest

View record in BASE

4

دورية أكاديمية

Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease

المؤلفون: Leeneman, B., Blommestein, H.M., Dongen-Leunis, A. van, Algeri, M., Fibbe, W.E., Oosten, L., Groot, C.U.D.A., Thielen, F.W.

المصدر: European Journal of Haematology

مصطلحات موضوعية: EORTC QLQ-C30, EQ-5D-5L, FACT-BMT, graft-versus-host disease, health-related quality of life, patient-reported outcomes

وصف الملف: application/pdf

العلاقة: lumc-id: 185656085; https://hdl.handle.net/1887/3731723Test

الإتاحة: https://doi.org/10.1111/ejh.13987Test
https://hdl.handle.net/1887/3731723Test

View record in BASE

5

دورية أكاديمية

المصدر: HemaSphere ; volume 7, issue S2, page 16-16 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000936176.74423.76Test

View record in BASE

6

دورية أكاديمية

PCN418 ASSESSMENT OF STUDIES EVALUATING INCREMENTAL COSTS, EFFECTIVENESS OR COST-EFFECTIVENESS OF SYSTEMIC THERAPIES IN BREAST CANCER BASED ON CLAIMS DATA: A SYSTEMATIC REVIEW

المؤلفون: Luyendijk, M., Vernooij, R.W.M., Blommestein, H.M., Siesling, S., Uyl-de Groot, C.A.

المصدر: Value in Health ; volume 22, page S517 ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2019.09.611Test
https://api.elsevier.com/content/article/PII:S1098301519329894?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301519329894?httpAccept=text/plainTest

View record in BASE

7

دورية أكاديمية

Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs

المؤلفون: Jongbloed, L., Blommestein, H.M., van Schoubroeck, H., Martens, J.W.M., Wilting, S.M., Uyl-de Groot, C.A., Jager, A.

المصدر: European Journal of Cancer ; volume 175, page S60-S61 ; ISSN 0959-8049

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1016/s0959-8049Test(22)01511-8
https://api.elsevier.com/content/article/PII:S0959804922015118?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0959804922015118?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

Micro-costing study of rituximab subcutaneous injection versus intravenous infusion in dutch setting

المؤلفون: Mihajlović, J., Bax, P., Van Breugel, E., Blommestein, H.M., Hoogendoorn, M., Hospes, W., Postma, M.J.

المصدر: Mihajlović , J , Bax , P , Van Breugel , E , Blommestein , H M , Hoogendoorn , M , Hospes , W & Postma , M J 2015 , ' Micro-costing study of rituximab subcutaneous injection versus intravenous infusion in dutch setting ' , Haematologica , vol. 100 , pp. 582 .

مصطلحات موضوعية: rituximab, subcutaneous drug administration, intravenous drug administration, European, hematology, injection, Netherlands, day care, spillage, drug cost, large cell lymphoma, patient, human, population